Initially, we sought to find genes with potential roles in BCR-ABL-independent TKI resistance by identifying those that are differentially expressed in TKI-resistant CML cells (Fig. 1A). Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.